TrialJournal of Zhejiang University. Science. B2025

Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depression.

Chunxiao Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.